The global sales of Cartilage Repair is estimated to be worth USD 1,474.6 million in 2024 and anticipated to reach a value of USD 2,767.9 million by 2034. Sales are projected to rise at a CAGR of 6.5% over the forecast period between 2024 and 2034. The revenue generated by Cartilage Repair in 2023 was USD 1,384.6 million.
Cartilage is a type of tissue located in the major joints such as hips, ankle, knees and other. It is a flexible tissue that provides support to the joints and prevents friction between two bones. As it has limited supply of blood vessel, it lack the ability to self-heal. Several factors, like sports or accidents, overuse, and conditions such as osteoarthritis, can cause its damage.
The cartilage damage will result in stiffness, pain and restricted movement in the joint that is impacted. Some key factors can be attributed to the growth of the cartilage repair industry are the rising number of sports-related injuries and rising number osteoarthritis cases are contributing factor to the demand for cartilage repair solutions.
Global Cartilage Repair Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 1,384.6 million |
| Estimated Size, 2024 | USD 1,474.6 million |
| Projected Size, 2034 | USD 2,767.9 million |
| Value-based CAGR (2024 to 2034) | 6.5% |
Various factors are driving the growth of the cartilage repair industry including increased number of joint injuries and degenerative diseases like osteoarthritis. With an increase in number of old age people and rise in high-impact sports the risk of cartilage damage has increased. This further increases the need for advanced repair techniques.
Moreover, as a result of the increasing advancement in medical technology, new techniques like autologous chondrocyte implantation, microfracture, and stem cell therapy have been invented that have not only improved the treatment results but have also increased the market opportunities. This technologies are more effective and have lesser recovery periods which has increased their preference among both patients and health providers.
For instance, according to the National Institute for Health and Care Excellence, an executive non-departmental public body of UK, each year more than 10,000 people in UK need cartilage repair treatment.
The investments made by governments and the private segments in healthcare are directly supporting the availability and adoption of advanced treatments. Apart from this increase in public awareness levels regarding the importance of joint health maintenance also help induce action in terms of reaching out for medical attention to attend to cartilage problems.
The current research and development supported by the collaboration of institutes and biotech firms are bound to bring out several innovative and better solutions for the repair of cartilages that will support market growth in the future.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global Cartilage Repair market's compound annual growth rate (CAGR) for the first half of 2023 and 2024 is compared in the table below. This analysis provides important insights into the performance of the industry by highlighting significant shifts and trends in revenue generation.
The first half (H1) is the period from January to June, and the second half (H2) is July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 7.3%, followed by a slightly lower growth rate of 7.0% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 7.3% (2023 to 2033) |
| H2 | 7.0% (2023 to 2033) |
| H1 | 6.5% (2024 to 2034) |
| H2 | 6.1% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 6.5% in the first half and remain relatively moderate at 6.1% in the second half. In the first half (H1) the industry witnessed a decrease of 80 BPS while in the second half (H2), the industry witnessed a decrease of 90 BPS.
Rising Incidence of Joint Disorders Driving the Market Growth
The rising incidence of disorders of the joints is gradually becoming a significant concern worldwide. Osteoarthritis, often abbreviated as OA, are degenerative joint diseases characterized by wearing down of the cartilage and bones at the ends of a joint. OA, therefore, is the most common form of arthritis that affects millions of people in the world, especially older adults.
For instance, according to the World Health Organization (WHO) there are around 528 million people worldwide currently living with osteoarthritis.
Another major driving force behind growth is increased participation in high-impact sports and physical activities. While indulging in physical activities the chances of cartilage or joint injuries are increased. Therefore, injuries during sports, such as torn cartilage in knees or shoulders, are becoming very common and will increase demand for their effective treatment solution.
Excess weight increases pressure in the joints, mainly in the lower part of the body, and increases the breakdown of cartilage in the joints, hence precipitating cartilage damage in the joints at an earlier age. Sedentary lifestyles also become prevalent, whereby lack of movement makes muscles and joints weak, hence vulnerable to damage.
Growing Adoption of Minimally Invasive Procedures is Driving the Industry Growth
The growing use of minimally invasive surgical procedures are among the major driving factors for the cartilage repair industry. Some examples of these minimally invasive procedures include techniques such as arthroscopy, microfracture, and minimally invasive autologous chondrocyte implantation and offers several advantage over traditional open surgical method.
The most attractive feature for them is substantially reduced recovery time. In most cases, patients treated with minimally invasive techniques would be informed to expect less pain after the procedure, shorter hospitalization, and an earlier return to normal activity.
Furthermore, all these techniques normally require much smaller incisions, which automatically means less trauma to the surrounding tissues. Moreover, healthcare providers are also coming forward to adopt minimally invasive approaches as they require less resource intensity and often tend to be less resource-intensive and more efficient, hence saving cost to the hospital and patients.
The wide adoption in these techniques is also supported by increasing the availability of advanced surgical tools and imaging technologies. Due to increasing awareness in patients and a desire to seek treatments associated with faster recovery and less pain, the minimally invasive procedure has been increased significantly.
Technological Advancement Creates Further Growth Opportunity for Cartilage Repair
There has been few advancement in treatment of damaged cartilage. Newer technologies have been developed for treatment of cartilage such as 3D bioprinting, gene therapy, and the advanced application of stem cells.
For example, state-of-the-art 3D bioprinting will enable making implants of custom design that would suit the anatomy of a patient, hence ensuring better integration and success rates for the patients who undergo such procedures. Another such technological advancement is gene therapy, which can be used to promote cartilage regeneration from within by modifying a patient's gene.
It might eventually eliminate the necessity of extensive procedures by simply enabling the body to repair the tissues more naturally. The technological advances both improve the potential and outcomes of the repair of the cartilage procedures as well as continue to explore the broader spectrum of available treatment.
As these technologies become more available and advanced, government will promote and offer reimbursement for the same, making advanced cartilage repair more readily available to the public. This ongoing innovation represents a significant opportunity for growth in the market as it meets the increasing demand for better and more personalized care.
High cost of Cartilage Repair may Restrict Market Growth
The high price of cartilage repair may act as a major restraining factor for the expansion of this industry. Such high price can make it inaccessible for numerous facilities such as smaller hospitals and clinics.
In a majority of cartilage repair cases highly expensive surgical intervention is required such as autologous chondrocyte implantation or osteochondral allograft transplantation. Most costs are incurred when advanced biomaterials, especially the use of hyaluronic acid and collagen scaffolds, are implemented. These techniques are not universally reimbursed and are out of reach for many, especially in the developing regions, thus compounding the cost of such treatment.
The adoption of economical and easy-to-maintain alternatives by patients is anticipated to pose a significant challenge for the cartilage repair industry. Despite several advantages, factors such as product recalls could lower the brand image of that particular manufacturer and impede growth of this industry.
In addition, other factors such as lack of availability of skilled professional, supply chain disruption, and other can also be factors which can act as an anchor to the industry’s growth.
Principal Consultant
The global Cartilage Repair industry recorded a CAGR of 5.9% during the historical period between 2019 and 2023. The growth of Cartilage Repair industry was positive as it reached a value of USD 2,767.9 million in 2034 from USD 1,474.6 million in 2024.
This sector is foreseen to grow positively in the near future, with a rise in incidences of cartilage damage through diseases like osteoarthritis. When the prevalence for osteoarthritis becomes common, proper treatment solutions, including cartilage repairs products, will be required correspondingly more often. In addition, rising number of people suffering from rheumatoid arthritis which destroys cartilage, will boost demand for cartilage repair products.
For instance, according to the Institute for Health Metrics and Evaluation, a USA-based non-government organization, there were around 17.6 million people living with rheumatoid arthritis globally in 2020. In addition, according to an article published in the Journal of Clinical Medicine, as of July 2021, about 1.5 million people or about 0.6 percent of the USA adult population have rheumatoid arthritis.
In 2020, this industry faced a temporary slowdown in its business due the impact of COVID-19. This was because different categories of businesses were forced to close down by the lockdown imposed by several government authority during the pandemic. However, post pandemic the industry experienced a gradual growth.
Furthermore, as the number of sports related injuries are rising worldwide the demand for proper cartilage repair will also increases. This would drive the industry growth over the forecast period.
For instance, according to The Johns Hopkins University, in USA more than 30 million children participate in some sort of sports. And around 3.5 million sports related injuries occurs each year within this children. Thus, as the number of sports-related injuries increases the demand for cartilage repair also increases.
Tier 1 companies are the industry leaders with a revenue of more than USD 100 million, or 59.5% of the global industry. These companies stand out for having a large product portfolio and a high production capacity.
These industry leaders also stand out for having a wide geographic reach, a strong customer base, and substantial experience in manufacturing and having enough financial resources which enables them to enhance their research and development efforts and expand into new industries.
The companies within tier 1 have a good reputation and high brand value. These companies frequently get involved in strategies such as acquisition and product launches. Prominent companies within tier 1 include Johnson & Johnson Services, Inc., Smith & Nephew plc, Zimmer Biomet, CONMED Corporation and Stryker
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a market share of 26.6% worldwide. These firms may not have cutting-edge technology or a broad global reach, but they do ensure regulatory compliance and have good technology. The players are more competitive when it comes to pricing and target niche markets. Key Companies under this category include Arthrex, Inc., Anika Therapeutics, Inc. and B. Braun SE
Compared to Tiers 1 and 2, Tier 3 companies offer Cartilage Repairs, but with smaller revenue spouts and less influence. These companies mostly operate in one or two countries and have limited customer base. The companies such as Collagen Solutions (US) LLC, Vericel Corporation Inc., and others falls under tier 3 category. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market analysis for Cartilage Repairs in various nations is covered in the section below. An analysis of important nations in North America, Asia Pacific, Europe, and other regions of the world has been mentioned below. It is projected that the United States will maintain its leading position in North America through 2034, holding a value share of 81.6%. By 2034, India is expected to experience a CAGR of 7.7% in the Asia-Pacific region.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 2.1% |
| Germany | 2.1% |
| France | 3.5% |
| UK | 2.5% |
| China | 6.8% |
| India | 7.7% |
| South Korea | 5.4% |
Germany’s Cartilage Repair market is poised to exhibit a CAGR of 2.1% between 2024 and 2034. The Germany holds highest market share in European market.
In Germany, there are many old people especially those who have reached 65 years of age. As people ages, the immune system became weak and chances of cartilage damage also increases. Again, the rising cases of joint-related diseases, such as osteoarthritis, further demand cartilage repair solutions. Besides this, the properly developed healthcare structure in this country and a strong focus on research and development work further support the growth.
Germany is home to the large number of leaders in medical technology companies and research institutions which are also involved in developing advanced techniques in cartilage repair through regenerative medicine and tissue engineering.
High expenditure on health alongside comprehensive insurance coverage secures better access to such advanced treatments. Growing awareness among the patients as well as healthcare providers about the long-term benefits of early intervention in joint disorders would also expand demand.
North America, spearheaded by the United States currently holds around 2.1% share of the global Cartilage Repair industry.
The United States is considered the most dominant market for cartilage repair across North America. Demand for cartilage repairs is increasing resulting from growth in the healthcare sector in the United States.
With the increase in healthcare spending, the country is investing more on technologically advance healthcare products to enhance care and patient outcomes. Additionally, the rising elderly population and rising burden of osteoarthritis is fueling healthcare needs including cartilage repair products.
Due to presence of large number of global leading biotech and pharma companies there is a continuous research and development in the cartilage repair sector in this country. In addition, the United States has a strong focus on minimally invasive procedures as it offers lesser recovery time and reduces overall healthcare costs.
Growing patient awareness and demand for effective, long-term solutions to joint problems further boost industry growth. As these trends continue, the cartilage repair market in the United States is expected to expand significantly.
In terms of industrial growth and infrastructure development, China is anticipated to be a strong contender, most importantly in the year 2023 the country is projected to show a CAGR of 6.8% between 2024 and 2034.
With the fast-growing number of cases diagnosed with osteoarthritis in China, it will therefore further boost the market for cartilage repair. With the increasing number of OA cases, innovative cartilage repair solutions and new treatments, like tissue engineering or surgical interventions, are much in demand. The more this burden of OA grows, the investments in research and development are likely to grow for effective treatments that will further boost the Chinese cartilage repair industry.
China is also turning into a central site for biotechnology and regenerative medicine research, allowing innovative and cost-effective treatment options to emerge. Furthermore, the rise in disposable incomes and increased health awareness of the population will boost demand for effective treatments and firmly establish China as a key growth market for cartilage repair in the upcoming years.
The section contains information about the leading segments in the industry. Based on application, the hyaline cartilage segment is expected to account for 66.4% of the global share in 2023.
| Application | Hyaline Cartilage |
|---|---|
| Value Share (2024) | 66.4% |
The hyaline cartilage segment is projected to be a dominating segment in terms of revenue, accounting for almost 66.4% of the market share in 2024. The hyaline cartilage segment is likely to dominate the market because it has a very important role in joint function, and damage is quite common in weight-bearing joints like those in the knees.
Hyaline cartilage covers the articulating ends of bones in the joints, providing for smooth movement at the joint and shock absorption. However, such cartilage is easily injured and undergoes degeneration, resulting in diseases like osteoarthritis that are becoming increasingly common.
With the naturally low healing potential of hyaline cartilage, this tissue type is a lead target for repair and regeneration therapies. Improving techniques, including autologous chondrocyte implantation and stem cell therapy, are mainly focused on the reconstitution of hyaline cartilage and, hence, foster growth in this segment.
Rising awareness of preserving joint function and, therefore, of the quality of life raises further demand for effective solutions for hyaline cartilage repair, thus securing its lead position.
| Site | Knee |
|---|---|
| Value Share (2024) | 31.7% |
The knee segment will dominate the industry in terms of revenue, accounting for almost 31.7% of the market share in 2024. This is due to the high prevalence of knee injuries and degenerative conditions such as osteoarthritis, which commonly affect the knee joint.
One of the most stressed joints in the body is the knee and in athletes and older people there high chances for damage to the cartilage in knee. Surgical techniques Innovations, especially in the area of minimally invasive arthroscopy and state-of-the-art cartilage regeneration therapies, such as autologous chondrocyte implantation and microfracture, have primarily been focused on knee repair.
Such kinds of treatments are quickly gaining in popularity since they restore joint function and reduce pain. Furthermore, growing awareness about the benefits of early intervention in case of knee cartilage injuries, coupled with a greater number of cases of knee replacement surgeries, is increasing this segment's growth and thus is expected to be dominating segment for cartilage repair.
The cartilage repair industry faces a high competition as there are large number of cartilage repair manufacturers. These manufacturers are focused on constantly innovating and improving their product portfolio.
Prominent producers of Cartilage Repairs are concentrating on growing internationally in order to increase their revenue and increase the size of their sales footprint in developing nations through the acquisition of regional small players. Manufacturers utilize various key strategies such as agreements, product launches, research sponsorship, and strategic collaborations to boost product sales and establish their market presence.
Recent Industry Developments in Cartilage Repair Market
In terms of application, the industry is divided into hyaline cartilage and fibrocartilage.
In terms of application, the industry is segregated into nee, hip, ankle & foot and others
In terms of distribution channel, the industry is divided into hospitals, clinics and ambulatory surgery centers
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East and Africa (MEA) have been covered in the report.
The global Cartilage Repair industry is projected to witness CAGR of 6.5% between 2024 and 2034.
The global Cartilage Repair industry stood at USD 1,384.6 million in 2023.
The global Cartilage Repair industry is anticipated to reach USD 2,767.9 million by 2034 end.
China is expected to show a CAGR of 6.8% in the assessment period.
The key players operating in the global Cartilage Repair industry Johnson & Johnson Services, Inc., Smith & Nephew plc, Zimmer Biomet, CONMED Corporation, Stryker, Collagen Solutions (US) LLC, Arthrex, Inc., Anika Therapeutics, Inc., B. Braun SE and Vericel Corporation.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. By Application 5.2. By Site 5.3. By End User 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 6.1. Hyaline Cartilage 6.2. Fibrocartilage 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Site 7.1. Knee 7.2. Hip 7.3. Ankle and Foot 7.4. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 8.1. Hospitals 8.2. Clinics 8.3. Ambulatory Surgery Centers 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 9.1. North America 9.2. Latin America 9.3. East Asia 9.4. South Asia and Pacific 9.5. Western Europe 9.6. Eastern Europe 9.7. Middle East and Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Application, Site and End User for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Johnson & Johnson Services, Inc. 19.2. Smith & Nephew plc 19.3. Zimmer Biomet 19.4. CONMED Corporation 19.5. Stryker 19.6. Collagen Solutions (US) LLC 19.7. Arthrex, Inc. 19.8. Anika Therapeutics, Inc. 19.9. B. Braun SE 19.10. Vericel Corporation
Explore Healthcare Insights
View Reports
Cartilage Repair Market
